Press relation & news

Press Release

Coalition Innovation Santé: Chronolife, with the support of Servier, Launches in France a Non-Invasive Telemonitoring Solution for the Continuous Monitoring of Patients Suffering from Chronic Diseases

Paris, (France) July 23rd, 2020 – As part of the Coalition Innovation Santé – Crise Sanitaire initiative, Chronolife and Servier are collaborating to accelerate the deployment of a non-invasive telemonitoring solution which aims to facilitate remote monitoring of chronic patients during the COVID-19 pandemic and enable healthcare professionals to provide better patient care.

During the Covid-19 pandemic, hospital bed occupancy rates in intensive care units were very high.

Read more

Coalition Innovation Santé : Chronolife, soutenu par Servier, déploie en France une solution de télésurveillance non invasive pour le suivi médical continu des patients souffrant de maladies chroniques

Paris, le 23 juillet 2020 – Chronolife et Servier s’associent dans le cadre de l’initiative Coalition Innovation Santé – Crise Sanitaire pour accélérer le déploiement d’une solution de télésurveillance non invasive qui vise à améliorer le suivi à distance des patients souffrant de maladies chroniques, en période de crise Covid-19, et à faciliter leur prise en charge par les professionnels de santé.

Pendant la période de pandémie du Covid-19,

Read more

Chronolife Achieves EU Medical Certification for KeeSense™ Remote Health-Monitoring Platform

Paris, 28, 2020 /PRNewswire/ — Chronolife, an artificial intelligence company specializing in digital health, today announced that it has secured Class IIa medical certification from the European Union for its groundbreaking medical-grade smart T-shirt, KeeSense™. The multi-sensor wearable device continuously monitors electrocardiography (ECG), thoracic respiration, abdominal respiration, skin temperature, thoracic impedance, and physical activity, enabling healthcare practitioners to remotely track vital clinical data about their patients. The platform’s receipt of a medical Conformité Européenne (CE) mark allows KeeSense™

Read more

Chronolife Applauded by Frost & Sullivan for Flagship Predictive Health Analytics and Monitoring Smartwear

Chronolife’s innovative T-shirt-based platform captures biometrics to track chronic conditions such as heart disease

LONDON, U.K. — December 5, 2019
Based on an in-depth analysis of the global predictive health analytics and monitoring market, Frost & Sullivan recognizes Chronolife, a pioneer in the wearable biometrics space, with the 2019 Global Visionary Innovation Leadership Award. Chronolife’s innovative clothing-integrated bio-sensing platform combines artificial intelligence (AI) with an accessible form factor to monitor and predict medical events in real time.

Read more

Chronolife, recently ISO 13 485 certified, receives CE mark approval for its Nexkin solution and announces a strategic partnership

Paris, France, 03 July 2019 – Chronolife, an artificial intelligence company specialized in digital health with a patented edge computing technology and algorithm named HOTS, receives CE (Conformité Européenne) marking in addition to FCC (Federal Communications Commission) certification for its Nexkin monitoring solution. Chronolife has also announced that it will collaborate with BePatient, specialized in e-health solutions.

The Nexkin solution developed by Chronolife includes a comfortable multi-sensory T-shirt that collects, stores,

Read more

Chronolife awarded at the 3rd French Edition of the “Trophées de l’embarqué et des objets connectés”

Paris (France), March 22, 2019 – Chronolife, an artificial intelligence company specialized in digital health, received special honors in the start-up category of the French award “Trophées de l’embarqué et des objets connectés”.

The 3rd edition of the “Trophées de l’embarqué et des objets connectés” (Embedded and Smart objects awards), organized in cooperation with the Electroniques magazine and the MtoM & Objets Connectés – Embedded Systems show, took place on March 20th,

Read more

Chronolife announces appointment of Dr. Zarifah Reed, M.D., as Chief Medical Officer as it prepares key clinical trial across Europe

Paris (France), March 12, 2019 – Chronolife, an artificial intelligence company specialized in digital health, announced the appointment of Dr. Zarifah Reed as Chief Medical Officer. In this role, Dr Reed will oversee the clinical development of Chronolife’s predictive and innovative solution for detection & prediction of worsening heart failure.

Chronolife’s predictive solution comprises of a washable T-Shirt capable of continuously collecting, storing and transmitting data, a smartphone application that receives,

Read more

Chronolife launches its connected T-Shirt manufacturing as well as key clinical trial across Europe

Paris (France), January 6th, 2019 – Chronolife, an artificial intelligence company specialized in digital health, announces the launch of the industrialization and production of its connected and washable T-shirt targeting pharma companies, insurance companies and preventive care service providers.

The company recently finalized the development of a washable T-shirt that continuously monitors and collects data on six physiological parameters (electrocardiogram, abdominal breathing, thoracic breathing, pulmonary impedance, physical activity and body temperature).

Read more

Laurent Vandebrouck appointed Chief Executive Officer of Chronolife

Paris (France), November 21, 2018

Chronolife is pleased to announce the appointment of Laurent Vandebrouck to the role of Chief Executive Officer. This start-up co-founded in November 2015 and funded by iBionext is an artificial intelligence company specialized in digital health. Chronolife is currently developing a unique solution which continuously monitors multiple parameters and capable of detecting specific changes in patient’s health.

Before joining Chronolife, Laurent was Managing Director of Qualcomm Life Europe,

Read more Chronolife